Avenzo Therapeutics, Inc. (“Avenzo”), a clinical-stage biotechnology company developing next-generation oncology therapies, ...

ALT001 was well tolerated in randomized Phase 1 ALS study, with early signals on Function and NfL; No treatment-related ...

TGM-148 is designed to combine hemostatic efficacy with a favorable safety profile and low treatment burden Tangram’s second asset to enter the clinic in 2026 Phase 1 trial will evaluate TGM-148 in ...

Topline Phase 1 proof-of-mechanism data anticipated in Q2 2027 Randomized, double-blind, placebo-controlled study will ...

Phase One, a leading developer of digital imaging technologies, has announced the successful launch and orbital deployment of an imaging sensor based on the Phase One iXM Series 150MP frame camera.

Huntsman Cancer Institute at the University of Utah stands at the forefront of innovative cancer research and treatment. Phase 1 clinical trials are key to finding better ways to treat cancer safely ...